Beta Bionics Inc., of Boston, and Copenhagen, Denmark-based Zealand Pharma A/S said the first patients have been dosed in a study evaluating the home use of dasiglucagon in the Ilet bionic pancreas system. The Ilet is a pocket-sized, wearable medical device that autonomously controls blood-sugar levels in diabetics. Read More
